Abiopharma

🔍 Hensley Jennifer M (Executive)

Company: PENTAIR plc (PNR)

Report Date: 2026-05-12

Detailed Transactions and Holdings:

• Sold 59 shares of Common Shares at $75.26 per share (Direct)
  Date: 2026-05-12 | Code: F | equity_swap_involved: false | shares_owned_after: 3,244.46 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Shares - Restricted Stock Units (Direct)
  Date: 2026-05-12 | Code: H | shares_owned_after: 2,341.45 | Footnotes: F3
• Holds 0 shares of Common Shares - ESOP (Direct)
  Date: 2026-05-12 | Code: H | nature_of_ownership: Plan Agent | shares_owned_after: 271.93 | Footnotes: F3

Footnotes:

• F1: Shares surrendered to pay taxes applicable to vesting of restricted stock units.
• F2: End-of-period holdings include monthly purchases under the ESPP in exempt transactions pursuant to Rule 16b-3(c).
• F3: End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a).
• F4: End-of-period holdings reflect the vesting of restricted stock units that were previously reported.